Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation

Scand J Rheumatol. 2017 Nov;46(6):509-511. doi: 10.1080/03009742.2017.1340512. Epub 2017 Aug 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute-Phase Proteins / analysis
  • Adult
  • Aged
  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / etiology
  • Dermatomyositis* / complications
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / immunology
  • Dermatomyositis* / physiopathology
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Interferon-Induced Helicase, IFIH1 / blood*
  • Interferon-Induced Helicase, IFIH1 / immunology
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / etiology
  • Lung Diseases, Interstitial* / physiopathology
  • Lung Diseases, Interstitial* / therapy
  • Male
  • Respiration, Artificial / methods
  • Respiratory Insufficiency / diagnosis
  • Respiratory Insufficiency / etiology
  • Shock, Septic / diagnosis
  • Shock, Septic / etiology
  • Treatment Outcome

Substances

  • Acute-Phase Proteins
  • Immunosuppressive Agents
  • IFIH1 protein, human
  • Interferon-Induced Helicase, IFIH1